|
Feature Article Consenting Subjects - Looking for Answers Mary A. Banks, RN, BS, BSN Educational Objectives:
Question: An IRB Coordinator said something to me about the "required elements of consent". I hate to admit it but I don't know what the required elements are. How can I be sure I have included them in my ICF?
Answer: Many survey studies do involve some risk to subjects. The level of risk depends on the questions being asked and whether the data is linked to individual subjects. Most often, the risk is the potential for harm due to loss of confidentiality. OHRP and FDA regulations require that, unless research is exempt, informed consent be obtained from each subject or his/her legally authorized representative (LAR). So, when you are doing non-exempt research involving surveys or questionnaires, you must obtain informed consent unless a Waiver of Informed Consent is granted by the IRB. Question:
Okay, but isn't it pretty obvious that I am going to need a waiver of
consent for my telephone survey research? What do I need to do for the
IRB to grant me this waiver? For non-FDA regulated studies, the OHRP regulations 45.CFR
46.116 allow the IRB to waive the requirement for informed consent
when the IRB determines that the research meets four criteria. These criteria,
found in Section J4 of INSPIR, are: In order for the IRB to approve a waiver of informed consent, investigators
must complete ALL FOUR ITEMS in Section J4 of INSPIR and explain specifically
how each of these criteria is met for this study. Of these four criteria,
often the most difficult to meet is the “practicability standard”
(criteria #3). In the case of your telephone survey, it would be unlikely
that the IRB would determine that it is impracticable for you to obtain
consent since you will be talking directly with subjects. So, in this
case the IRB probably would NOT agree to waive all elements of consent.
Question: You're kidding! But I think that the study can not "practicably be carried out" if we have to wait for every subject to mail back his/her signed consent form. Is there anything I can do about this?
Answer: Each institution sets its own guidelines in conformity with state laws for who can sign an ICF as a LAR and when. The BUMC IRB recently clarified its standards and created an algorithm to help investigators determine when consent by LAR can be approved and who can be the LAR. This issue was discussed in detail in the November 2005 CR Times Feature Article. The algorithm can also be found on the BUMC IRB website.
Question: I am the PI on a BUMC study and also the PI on the grant. I have co-investigators at the VA Hospital and at UMass. We plan to enroll subjects at each of these three locations. Do all of the subjects have to be consented using the BUMC consent form? Answer: Under most circumstances the ICF from the institution where the subject is being consented will be used to obtain consent. So, in this situation, the study will probably be reviewed by the BUMC IRB, the VA IRB, and the UMass IRB. A consent form will be created at each institution using their letterhead and their institution-specific ICF wording. The BUMC IRB will be responsible for reviewing, approving and validating only the BUMC consent form. Occasionally the BUMC IRB asks to see the other ICFs (attached in Section S), but the BUMC IRB will NOT stamp other institutions’ consent forms.
Answer: The most important issue here is that any person who is charged with obtaining consent must have the appropriate background, training and understanding of the research to appropriately present the research to subjects and answer their questions. He/she must also have an understanding of human subjects’ rights related to their participation in research. BUMC has specific requirements for any person who will be consenting
subjects. He/she must provide the IRB with documentation of training in
human subjects protection. All persons who have provided this documentation
are listed on the IRB
website. Secondly, he/she must be listed as a co-investigator in Section
A4 of INSPIR. Finally, in Section J2 of INSPIR, the PI must explain to
the IRB precisely who will consent subjects. The IRB may require specific
qualifications depending on the complexities and risks of the study.
Answer: First, you must always only use consent forms that have been approved by the IRB. Approved consent forms have a validation date and expiration date in the footer of each page of the consent. Consents that have not yet been fully approved do not have an “approved” footer and have a “NOT CURRENTLY APPROVED” watermark across each page. When an amendment is submitted, the attached consent automatically contains the “NOT CURRENTLY APPROVED” watermark. Once the amendment is approved, the new version of the consent form becomes the “APPROVED” version. The previously approved version of the protocol is archived and the consent form attached to the archived version then gets the “NOT CURRENTLY APPROVED” watermark. Once it has the “NOT CURRENLTY APPROVED” watermark, it is obsolete and should not be used any longer. The best way to ensure that you are using the correct version of the
consent form at all times is to only print consent forms as you need them.
If for some reason you must pre-print consent forms in batches, then each
time a new amendment is approved you must print new consent forms and
destroy all old printed consents because they are no longer valid. Answer: It IS true! This change was announced in last month’s issue of the CR Times (December 2005) Feature Article. HIPAA language will be included in the ICF for new protocols created as of January 9, 2006. If HIPAA authorization is required, the investigator must:
b. Check the box next to HIPAA authorization language c. Go to Section Q (consent form) and you will find the HIPAA authorization language in the last section of the consent d. Modify the templated HIPAA language as appropriate. Only the details of the authorization wording should be modified as appropriate, not the main headings which are required core elements of HIPAA Authorization. e. When the protocol and ICF are approved, the HIPAA authorization language is also approved. For more details go to the research HIPAA website at www.bumc.bu.edu/hipaa. Quiz This Quiz applies to the recertification period from July 1, 2007 to June 30, 2009. CME credits are also available. Click
here and close window if you are a BUMC researcher |